Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
WW
WW International, Inc. Common Stock
WW
Mkt Cap
$129.7M
Volume
176.74K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
WW
WW
WW
WW International, Inc. Common Stock
WW
News
·
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Mkt Cap
$146.3M
Volume
176.74K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Weight Watchers expanded its GLP-1 weight-loss medication access by joining Eli Lilly's LillyDirect platform, combining branded medications with clinical support. Meanwhile, Eli Lilly partnered with Ascidian Therapeutics on RNA-based kidney disease treatments with potential deal value reaching $1.9 billion. Eli Lilly shares surged 5.13% to $1,134.08.
Benzinga · Jun 4, 2026
Weight Watchers Announces Leadership Transition and Board Updates
Weight Watchers (WW) announced that CEO Tara Comonte departed effective March 31, 2026. The company established an Office of the CEO led by CFO Felicia DellaFortuna and COO Jon Volkmann, with an interim CEO to be appointed. A Transition Committee was formed to oversee operations and conduct a comprehensive CEO search. The company reaffirmed its Q1 2026 subscriber estimates and full year 2026 financial guidance. Additionally, Debra Cotter was appointed as chief legal officer, and two board directors resigned.
GlobeNewswire Inc. · Apr 3, 2026
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
Amazon has entered the GLP-1 weight loss drug market by offering Novo Nordisk's Wegovy pill through its pharmacy service at competitive prices ($25-$149 per month). This move could significantly impact competitors like Hims & Hers, WW International, and GoodRx, as Amazon leverages its 200 million Prime members and e-commerce platform. While the pill form is expected to drive overall GLP-1 adoption, Amazon's scale and reach pose a competitive threat to specialized GLP-1 retailers.
The Motley Fool · Feb 6, 2026
Weight Watchers to Participate in Upcoming Investor Conferences
WW International announced its participation in two investor conferences in January 2026: the ICR Conference (January 12-13) in Orlando, FL and CJS Securities' 26th Annual New Ideas for the New Year (January 14) with a virtual fireside chat. The company will host investor meetings at both events.
GlobeNewswire Inc. · Jan 7, 2026
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
Novo Nordisk launched its Wegovy weight loss pill in US pharmacies in December 2025 with competitive pricing starting at $149/month for self-pay patients. The pill demonstrated 17% average weight loss versus 3% for placebo. It's available through major retailers including CVS and Costco, as well as telehealth providers. Despite the positive product launch, NVO stock remains down 35.61% over the past year and trades 8.4% below its 200-day moving average.
Benzinga · Jan 5, 2026
Weight Management Market Outlook to 2030: 7.6% CAGR as Digital Adoption Rises and Preventive Health Focus Strengthens, Says Mordor Intelligence
The global weight management market is valued at USD 39.07 billion in 2025 and is projected to reach USD 60.48 billion by 2030, growing at a 7.6% CAGR. Growth is driven by rising obesity prevalence, digital platform adoption, and a shift toward holistic, sustainable weight management programs. North America leads the market while Asia-Pacific is the fastest-growing region.
GlobeNewswire Inc. · Dec 24, 2025
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
WeightWatchers introduces a specialized menopause program offering personalized medical care, nutrition guidance, and community support, with Queen Latifah as its spokesperson to address women's health needs during menopause.
GlobeNewswire Inc. · Sep 8, 2025
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program
WeightWatchers introduces a comprehensive menopause program targeting women's health, featuring Queen Latifah as spokesperson. The program offers personalized medical care, nutrition guidance, and community support specifically designed for women experiencing perimenopause and postmenopause.
GlobeNewswire Inc. · Sep 8, 2025
WeightWatchers treibt internationales Wachstum mit strategischer Verstärkung im Führungsteam voran
WeightWatchers appointed Alejandro Bethlen as Executive Vice President International to lead global expansion and innovation, leveraging his extensive experience in global business development across consumer and e-commerce sectors.
GlobeNewswire Inc. · Sep 3, 2025
WeightWatchers Advances International Growth With Strategic Leadership Appointment
WeightWatchers appointed Alejandro Bethlen as Executive Vice President, International, to drive global growth and innovation. Bethlen brings extensive experience from Zooplus, Amazon, and other consumer-focused companies to expand the company's international presence.
GlobeNewswire Inc. · Sep 3, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
WW
WW
WW International, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
WW
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any WW yet.
Related Tickers
Earnings